SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

November, 2023

 

Commission File Number 1-15182

 

DR. REDDY’S LABORATORIES LIMITED

(Translation of registrant’s name into English)

 

8-2-337, Road No. 3, Banjara Hills

Hyderabad, Telangana 500 034, India

+91-40-49002900

 

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F x                                  Form 40-F ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ______

 

Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ______

 

Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

 

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

 

Yes ¨                                  No x

 

If “Yes” is marked, indicate below the file number assigned to registrant in connection with Rule 12g3-2(b): 82-________.

 

 

 

 

 

 

EXHIBITS

 

Exhibit

Number

  Description of Exhibits
     
99.1   Intimation on results of voting results through postal ballot dated November 16, 2023

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

DR. REDDY’S LABORATORIES LIMITED

(Registrant)

     
Date: November 16, 2023 By: /s/ K Randhir Singh
    Name: K Randhir Singh
    Title: Company Secretary

 

 

 

 

 

Exhibit 99.1

 

Dr. Reddy’s Laboratories Ltd.

8-2-337, Road No. 3, Banjara Hills,

Hyderabad - 500 034, Telangana,
India.

CIN : L85195TG1984PLC004507  

 

Tel      : +91 40 4900 2900

Fax     : +91 40 4900 2999

Email : mail@drreddys.com

www.drreddys.com

 

November 16, 2023

 

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY-EQ)

BSE Limited (Scrip Code: 500124)

New York Stock Exchange Inc. (Stock Code: RDY)

NSE IFSC Ltd (Stock Code: DRREDDY)

 

Dear Sir/Madam,

 

Sub:Results of voting through Postal Ballot (remote e-voting) pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

 

This is in furtherance to our letter dated October 16, 2023 enclosing therein Notice of Postal Ballot for seeking approval of Members of the Company, regarding the appointment of Dr. Alpna Hansraj Seth (DIN: 01183914), as an Independent Director of the Company, for a term of five consecutive years effective from September 19, 2023, in terms of Section 149 of the Companies Act, 2013, by way of special resolution through voting by electronic means (remote e-voting).

 

We would like to inform that the special resolution mentioned in the said Postal Ballot Notice have been passed by the Members of the Company with requisite majority.

 

In accordance with Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the summarized voting result of the remote e-voting, in the prescribed format, along with a copy of the Scrutinizer’s Report are enclosed herewith, for your information and records.

 

Thanking you.

 

Yours faithfully,

For Dr. Reddy’s Laboratories Limited

 

 

 

K Randhir Singh

Company Secretary, Compliance Officer and Head-CSR

 

CC: National Securities Depositary Limited (NSDL)

 

 

 

 

Scrutinizer’s Report

[Pursuant to Sections 108 and 110 of the Companies Act, 2013 and

Rules 20 and 22 of the Companies (Management and Administration) Rules, 2014]

 

To,

The Chairman

Dr. Reddy’s Laboratories Limited

8-2-337, Road No. 3, Banjara Hills,

Hyderabad, Telangana- 500034

 

Sub: Scrutinizer’s Report on voting through E-voting for Postal Ballot in terms of Sections 108 and 110 of the Companies Act, 2013 read with Rules 20 and 22 of the Companies (Management and Administration) Rules, 2014

 

Dear Sir,

 

I, Kanchan Sharma, Partner, M/s. Mehta & Mehta, Practicing Company Secretaries have been appointed as a Scrutinizer by the Board of Directors of Dr. Reddy’s Laboratories Limited (“Company”) for the purpose of scrutinizing the Postal Ballot remote e-voting process carried out by the Company as per Sections 108, 110 and other applicable provisions, if any, of the Companies Act, 2013 and Rules 20 and 22 of the Companies (Management and Administration) Rules, 2014 read with the General Circular No. 14/2020 dated April 8, 2020, the General Circular No. 17/2020 dated April 13, 2020, and the General Circular No. 22/2020 dated June 15, 2020, the General Circular No. 33/2020 dated September 28, 2020, the General Circular No. 39/2020 dated December 31, 2020, the General Circular No. 10/2021 dated June 23, 2021 and the General Circular No. 20/2021 dated December 8, 2021, General Circular No. 03/2022 dated May 05, 2022, General Circular Nos. 11/2022 dated December 28, 2022 and 9/2023 dated September 25, 2023, issued by the Ministry of Corporate Affairs, Government of India (the “MCA Circulars”), Regulation 44 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Secretarial Standards on General Meetings (“SS-2”) issued by the Institute of Company Secretaries of India on the resolution as mentioned in the Notice of Postal Ballot dated October 12, 2023 in a fair and transparent manner and do hereby submit the report as under:

 

1.The Notice of Postal Ballot (“Notice”) was dispatched to the members of the Company vide e-mail on Monday, October 16, 2023.

 

2.The remote e-voting period commenced on Tuesday, October 17, 2023 (09.00 a.m. IST) and ended on Wednesday, November 15, 2023 (05:00 p.m. IST).

 

3.The remote e-voting facility was provided by National Securities Depository Limited (“NSDL”).

 

 

 

 

4.The Notice of Postal Ballot was sent in electronic form only to all the shareholders whose email addresses are registered with Depository Participants / Bigshare Services Pvt. Ltd, Registrar and Share Transfer Agent of the Company and whose names appear in the Register of Members/ List of Beneficial Owners as received from Depositories i.e., National Securities Depository Limited/ Central Depository Services (India) Limited.

 

5.The hard copies of the Notice along with Postal Ballot forms and pre-paid business envelope were not sent to the Members for the Postal Ballot in accordance with the requirements specified under the MCA Circulars. Accordingly, the communication of the assent or dissent of the Members took place through the remote e-voting system only.

 

6.The Members of the Company holding shares as on the “cut-off” date i.e., Friday, October 6, 2023 were entitled to vote on the proposed resolution.

 

7.The result of the scrutiny of the above postal ballot through remote e-voting in respect of passing of resolution contained in the Notice dated October 12, 2023 is as under:

 

Ordinary Resolution – Approval of the appointment of Dr. Alpna Hansraj Seth (DIN: 01183914), as an Independent Director of the Company

 

Votes in favour of the resolution:

 

Number of members

who voted

Number of votes cast by

them

% of total number of valid

votes cast

2267 131,601,358 99.6165%

 

Votes against the resolution:

 

Number of members

who voted

Number of votes cast by

them

% of total number of valid

votes cast

84 506,595 0.3835%

 

Invalid/Abstained votes:

 

Total number of members whose votes were

declared invalid/abstained

Total number of votes cast by

them

0 0

 

The Special resolution has been passed, since the votes cast in favour of the resolution are three times more than the votes cast against the resolution.

 

 

 

 

The register, in accordance with Rule 20(4)(xiv) and Rule 22(10) of the Companies Management & Administration) Rules. 2015. has been maintained electronically to record the assent or dissent received, mentioning the particulars of name, address, folio number or client ID of the shareholders, number of shares held by them. There were no shares with differential voting rights in the Company, hence there is no requirement of maintaining of the list of shares with differential voting rights

 

9.The related papers with respect to Postal Ballot will be handed over to the Company for safe custody of the same after the Chairman or any person authorized by him, signs the minutes/report of Postal Ballot process.

 

Thanking You.  
   
For Mehta & Mehta  
Company Secretaries  
   
 
   
Kanchan Sharma  
Scrutinizer  
ACS No: 44664  
CP No: 25913  
UDIN: A044664E001889507  
Place: Hyderabad  
Date: November 16, 2023  
   
Countersigned by  
   
   
(Person authorized by Chairman)  
K Randhir Singh  
Company Secretary. Compliance Officer, and Head- CSR  
Dr. Reddy’s Laboratories Limited  
Membership No: F6621  

 

 

 

 

General information about company
Scrip code 500124
NSE Symbol DRREDDY
MSEI Symbol NOTLISTED
ISIN INE089A01023
Name of the company Dr. Reddy's Laboratories Limited
Type of meeting Postal Ballot
Date of the meeting / last day of receipt of postal ballot forms (in case of Postal Ballot) 15-11-2023
Start time of the meeting  
End time of the meeting  

 

Scrutinizer Details
Name of the Scrutinizer Kanchan Sharma
Firms Name Mehta & Mehta
Qualification CS
Membership Number A44664
Date of Board Meeting in which appointed 19-09-2023
Date of Issuance of Report to the company 16-11-2023

 

Voting results
Record date 06-10-2023
Total number of shareholders on record date 254787
No. of shareholders present in the meeting either in person or through proxy
a) Promoters and Promoter group  
b) Public  
No. of shareholders attended the meeting through video conferencing
a) Promoters and Promoter group  
b) Public  
No. of resolution passed in the meeting 1

 

 

 

 

 

  

Resolution (1)
Resolution required: (Ordinary / Special) Special
Whether promoter/promoter group are interested in the agenda/resolution? No
Description of resolution considered Approval of appointment of Dr. Alpna Hansraj Seth (DIN: 01183914), as an Independent Director in terms of Section 149 of the Companies Act, 2013

Category Mode of voting

No. of shares

held

No. of votes

polled

% of Votes

polled on

outstanding

shares

No. of votes –

in favour

No. of votes –

against

% of votes in

favour on votes

polled

% of Votes

against on votes

polled

    (1) (2) (3)=[(2)/(1)]*100 (4) (5) (6)=[(4)/(2)]*100 (7)=[(5)/(2)]*100
Promoter And Promoter Group E-Voting   44461128 100.0000 44461128 0 100.0000 0.0000
Poll            

Postal Ballot (if

Promoter

applicable)

44461128            

Total

44461128 44461128 100.0000 44461128 0 100.0000 0.0000
Public- Institutions E-Voting   87466428 81.8048 86984701 481727 99.4492 0.5508
Poll              

Postal Ballot (if

applicable)

106920845            
Total 106920845 87466428 81.8048 86984701 481727 99.4492 0.5508
  E-Voting   180397 1.1712 155529 24868 86.2148 13.7852
Public- Non Institutions Poll            

Postal Ballot (if

applicable)

15402791            
Total 15402791 180397 1.1712 155529 24868 86.2148 13.7852
Total 166784764 132107953 79.2086 131601358 506595 99.6165 0.3835

 

Details of Invalid Votes
Category No. of Votes
Promoter and Promoter Group 0
Public Insitutions 0
Public - Non Insitutions 0

 

 

 

 

 

 


Dr Reddys Laboratories (NYSE:RDY)
Historical Stock Chart
Von Apr 2024 bis Mai 2024 Click Here for more Dr Reddys Laboratories Charts.
Dr Reddys Laboratories (NYSE:RDY)
Historical Stock Chart
Von Mai 2023 bis Mai 2024 Click Here for more Dr Reddys Laboratories Charts.